Catalyst Capital Advisors »

Alnylam Pharmaceuticals shares owned by Catalyst Capital Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Catalyst Capital Advisors from 13F filings

Historical chart of Catalyst Capital Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Catalyst Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Catalyst Capital Advisors

Quarter filed Position value Share count Share price at filing
2012-06-30 $7.0k 586 11.95

More positions owned by Catalyst Capital Advisors

Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci India Etf (INDA)
Vanguard Index Fds Large Cap Etf (VV)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Rus Mid Cap Etf (IWR)

View all positions for Catalyst Capital Advisors

Top funds holding Alnylam Pharmaceuticals

FMR
Vanguard Group
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Dodge & Cox
T. Rowe Price Investment Management
Wellington Management Company
American Century Companies

View all funds holding Alnylam Pharmaceuticals